GERMANTOWN, Md., Nov. 7, 2013 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced financial results for the third quarter of 2013.
Third Quarter Highlights
Highlights for the third quarter of 2013 include:
-- Net income attributable to Intrexon was $15.4 million, or $0.15 cents per common share, for the quarter ended September 30, 2013 compared to a net loss attributable to Intrexon of $20.5 million for the quarter ended September 30, 2012;
Help employers find you! Check out all the jobs and post your resume.
